Market Value3,417,745,000
Total Holdings82
File Date2019-05-20
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
TNDM / Tandem Diabetes Care, Inc.
RGEN / Repligen Corporation
CVS / CVS Health Corporation
ATRC / AtriCure, Inc.
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
ANAB / AnaptysBio, Inc.
ARVN / Arvinas, Inc.
NITE / Capitol Series Trust - The Nightview Fund
VCEL / Vericel Corporation
QURE / uniQure N.V.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
REPL / Replimune Group, Inc.
SRRK / Scholar Rock Holding Corporation
BOLD / Boundless Bio, Inc.
TCRR / Tcr2 Therapeutics Inc
OVID / Ovid Therapeutics Inc.
LHCG / LHC Group Inc
FLXN / Horizon Funds - Horizon Flexible Income ETF
US62857M1053 / MyoKardia, Inc.
SGRY / Surgery Partners, Inc.
GOSS / Gossamer Bio, Inc.
LOGC / ContextLogic Holdings Inc.
EPZM / Epizyme Inc
ODT / Odonate Therapeutics Inc
RGNX / REGENXBIO Inc.
SYRS / Syros Pharmaceuticals, Inc.
HSKA / Heska Corp. (Restricted Voting)
US29266S3040 / Endologix, Inc.
SIBN / SI-BONE, Inc.
US014339AA35 / Alder Biopharmaceuticals Inc Bond
04269XAB1 / Array Biopharma Inc Bond
ACRS / Aclaris Therapeutics, Inc.
AVDR / New Age Alpha Trust - AVDR US LargeCap Leading ETF
XNCR / Xencor, Inc.
SAGE / Sage Therapeutics, Inc.
SWAV / Shockwave Medical, Inc.
JNCE / Jounce Therapeutics Inc
/ Oxford Immunotec Global PLC
SBBP / Strongbridge Biopharma plc
ALGN / Align Technology, Inc.
CI / The Cigna Group
CELG / Celgene Corp.
CSLT / Castlight Health Inc - Class B
NVRO / Nevro Corp.
ADVM / Adverum Biotechnologies, Inc.
ALDR / Alder BioPharmaceuticals, Inc.
IFRX / InflaRx N.V.
98235T107 / Wright Medical Group N.V.
GLYC / GlycoMimetics, Inc.
BIIB / Biogen Inc.
AUPH / Aurinia Pharmaceuticals Inc.
VAPO / Vapotherm, Inc.
MOR / MorphoSys AG - Depositary Receipt (Common Stock)
TDOC / Teladoc Health, Inc.
US69354M1080 / PRA Health Sciences Inc
US28249H1041 / Eidos Therapeutics, Inc.
AXNX / Axonics, Inc.
TCDA / Tricida Inc
PEN / Penumbra, Inc.
GBT / Global Blood Therapeutics Inc.
MDT / Medtronic plc
CMRX / Chimerix, Inc.
VKTX / Viking Therapeutics, Inc.
ICUI / ICU Medical, Inc.
GWP / GW Pharmaceuticals plc
/ Array BioPharma, Inc.
ELV / Elevance Health, Inc.
NVTA / Invitae Corporation
DCPH / Deciphera Pharmaceuticals, Inc.
FATE / Fate Therapeutics, Inc.
UNH / UnitedHealth Group Incorporated
EHTH / eHealth, Inc.
WVE / Wave Life Sciences Ltd.
IRTC / iRhythm Technologies, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
CBAY / CymaBay Therapeutics, Inc.
XERS / Xeris Biopharma Holdings, Inc.
IMGN / ImmunoGen, Inc.
JAZZ / Jazz Pharmaceuticals plc
BMY / Bristol-Myers Squibb Company
CLVS / Clovis Oncology Inc
ALLK / Allakos Inc.
LIVN / LivaNova PLC
GRTSQ / Gritstone bio, Inc.
KRYS / Krystal Biotech, Inc.
ESTA / Establishment Labs Holdings Inc.
ATRA / Atara Biotherapeutics, Inc.
FOLD / Amicus Therapeutics, Inc.